American Biogenetic Sciences, Inc. - Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Net loss	$ (77,016)	$ (62,792)
Expenses paid by issuance of common stock	0	0
Fair value of services provided by related parties	61,000	46,000
Increase (decrease) in accounts payable and accrued expenses	13,016	16,792
Cash flows used by operating activities	(3,000)	0
Cash used in investing activities	0	0
Procceds from related party borrowings	3,000	0
Cash generated by financing activities	3,000	0
Change in cash	0	0
Cash - beginning of period	0	0
Cash - end of period	$ 0	$ 0